The clinical relevance of DNMT1 and DACH1 requires further validation in larger, multicenter cohorts and preclinical therapeutic studies to provide a more comprehensive understanding of the DNMT1-DACH1 regulatory axis and its potential clinical applications in CRC patients. The gene discussed is DNMT1; the disease is colorectal carcinoma.